WeVote
Log In

Bill

Bill

HB 1187

Drugs, Prescription - As introduced, deletes an obsolete provision that required the comptroller of the treasury, in conjunction with any appropriate TennCare drug utilization review committees, to study the use of prescription drugs in nursing homes and the costs of those prescription drugs for residents of nursing homes; to examine prescription use overall; to focus on any practices that would improve the quality of resident care while reducing costs to the TennCare program; and to report by January 1, 2005, to the speaker of the senate and the speaker of the house of representatives. - Amends TCA Title 4; Title 33 and Title 71.

114th Regular Session (2025-2026) Introduced by Gary Hicks

HB 1187 deletes a 20-year-old expired statutory mandate requiring the Tennessee Comptroller to study prescription drug use and costs in nursing homes.

Sponsor(s) withdrawn.
#drugs #prescription
0
WeVote Research Nonpartisan
Bill Summary · HB 1187

Legislative bill overview

HB 1187 removes an obsolete statutory requirement that mandated the Tennessee Comptroller of the Treasury, working with TennCare drug utilization review committees, conduct a study on prescription drug use and costs in nursing homes and submit findings by January 1, 2005. Since that deadline passed nearly 20 years ago, this bill eliminates the outdated mandate from state law.

Why is this important

This is a housekeeping measure that cleans up Tennessee's legal code by removing provisions that no longer have any practical effect. While seemingly minor, such cleanup bills prevent confusion about what statutory obligations actually remain in force and reduce administrative burden by eliminating references to long-past deadlines.

Potential points of contention

  • Minimal controversy expected: This addresses an already-missed deadline from 2005, making it largely uncontroversial
  • Whether the study's findings remain relevant: Some may question if removing the requirement also implies previous findings are no longer consulted for policy decisions
  • Broader prescription drug oversight: The removal doesn't establish new monitoring mechanisms, so stakeholders concerned with nursing home drug costs may prefer the statute remain as a symbolic commitment to oversight

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.